Biocon LimitedNSE: BIOCON

Press Release Jul 03 2025

Jul 3, 2025 at 12:21 PM UTC · Issued by Biocon Limited

Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled "Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars".

View Attachment